Suven Life Sciences achieved 100% patient enrolment in Phase-2b clinical trial of Ropanicant for MDO
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The company had achieved the highest "A" rating in Climate Change
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
Expands bioprocessing footprint across Asia
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
Subscribe To Our Newsletter & Stay Updated